Interoception and pediatric occupational therapy practice: a protocol for a scoping review / Interocepção e prática da terapia ocupacional pediátrica: um protocolo para uma revisão de escopo

Abstract Introduction Interoception is relatively new within pediatric occupational therapy practice. Interoception allows us to feel and interpret internal body sensations and is related to our ability to regulate emotions and behavior. It is associated with other functions including sensory processing, self-regulation and executive functioning, making it important for everyday participation in life activities. Pediatric occupational therapists are considering interoception as part of intervention but there is limited research to understand how and why occupational therapists use interoception in clinical practice. Objectives The aim of this protocol is to describe the methodology and analyses to be used to undertake a scoping review. Method This paper presents the protocol for a scoping review. A search of literature from ten electronic databases (Ovid Medline, Ovid Embase, Ovid PsycINFO, ERIC, Scopus, CINAHL, ProQuest Dissertations & Theses Global, AMED, OTDBASE and Google Scholar), grey literature and article reference searching was conducted. Title and abstract screening was completed before full-text review. Selected articles met stringent inclusion criteria. The PRISMA-ScR Checklist was used alongside the Crowe Critical Appraisal Tool to ensure robust data extraction and synthesis from selected studies. Results A total of 2449 articles were retrieved. Eighteen articles were included in the review. A narrative synthesis approach will be used to synthesise data. Conclusion Findings from this scoping review will inform future research related to interoception and pediatric occupational therapy practice to support clinicians to consider evidence to underpin practice.

Resumo Introdução A interocepção é relativamente nova na prática da terapia ocupacional pediátrica. A interocepção nos permite sentir e interpretar sensações internas do corpo e está relacionada à nossa capacidade de regular emoções e comportamentos. Está associado a outras funções, incluindo processamento sensorial, autorregulação e funcionamento executivo, tornando-o importante para a participação diária nas atividades da vida. Os terapeutas ocupacionais pediátricos estão considerando a interocepção como parte da intervenção, mas há pesquisas limitadas para entender como e por que os terapeutas ocupacionais usam a interocepção na prática clínica. Objetivos O objetivo deste protocolo é descrever a metodologia e as análises a serem utilizadas para realizar uma revisão de escopo. Método Este artigo apresenta o protocolo para uma revisão de escopo. Foi realizada uma pesquisa de literatura em dez bases de dados eletrônicas (Ovid Medline, Ovid Embase, Ovid PsycINFO, ERIC, Scopus, CINAHL, ProQuest Dissertations & Theses Global, AMED, OTDBASE e Google Scholar), literatura cinzenta e pesquisa de referências de artigos. A triagem do título e do resumo foi concluída antes da revisão do texto completo. Os artigos selecionados atenderam a critérios de inclusão rigorosos. A lista de verificação PRISMA-ScR foi usada juntamente com a Crowe Critical Appraisal Tool para garantir a extração e síntese robusta de dados dos estudos selecionados. Resultados Foram recuperados 2.449 artigos. Dezoito artigos foram incluídos na revisão. Uma abordagem de síntese narrativa será usada para sintetizar os dados. Conclusão Os resultados desta revisão de escopo informarão pesquisas futuras relacionadas à interocepção e à prática de terapia ocupacional pediátrica para apoiar os médicos a considerarem evidências para sustentar a prática.

Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer.

BACKGROUND: We assessed health-related quality of life (symptoms of therapy/patient functioning/global health status), in APHINITY (pertuzumab/placebo, trastuzumab, and chemotherapy as adjuvant HER2-positive early breast cancer therapy). METHODS: Patients received 1 year/18 cycles of pertuzumab/placebo with trastuzumab and chemotherapy and completed EORTC QLQ-C30 and BR23 questionnaires until 36 months post-randomisation/disease recurrence. Changes ≥10 points from baseline were considered clinically meaningful. RESULTS: 87-97% of patients completed questionnaires. In the pertuzumab versus placebo arms, mean decrease in physical function scores (baseline → end of taxane) was -10.7 (95% CI -11.4, -10.0) versus -10.6 (-11.4, -9.9), mean decrease in global health status was -11.2 (-12.2, -10.2) versus -10.2 (-11.1, -9.2), and mean increase in diarrhoea scores (baseline → end of taxane) was +22.3 (21.0, 23.6) versus +9.2 (8.2, 10.2). Diarrhoea scores remained elevated versus baseline in the pertuzumab arm throughout HER2-targeted treatment (week 25: +13.2; end of treatment: +12.2). Role functioning was maintained in both arms. CONCLUSIONS: Improved invasive disease-free survival achieved by adding pertuzumab to trastuzumab and chemotherapy did not adversely affect the ability to conduct activities of daily living versus trastuzumab and chemotherapy alone. Patient-reported diarrhoea worsened during taxane therapy in both arms, persisting during HER2-targeted treatment in the pertuzumab arm. CLINICALTRIALS.GOV: NCT01358877.